Evidence map›Paper›PMID 32957938›Full record

ArticleBMC infectious diseases2020

Signs and symptoms do not predict, but may help rule out acute Q fever in favour of other respiratory tract infections, and reduce antibiotics overuse in primary care.

Volker H Hackert, Nicole H T M Dukers-Muijrers, Christian J P A Hoebe

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. A case report of Vancomycin in the treatment of Q fever endocarditis.Frontiers in cellular and infection microbiology · 2024
    Article
  2. Case Report of Acute Q Fever with Hepatitis Progressing to Chronic Q Fever with Endocarditis.Journal of community hospital internal medicine perspectives · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Volker H HackertDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, 6411, TE, The Netherlands. volker.hackert@ggdzl.nl.ORCID http://orcid.org/0000-0003-1025-4381
Nicole H T M Dukers-MuijrersDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, 6411, TE, The Netherlands.
Christian J P A HoebeDepartment of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, 6411, TE, The Netherlands.
Maastricht University Medical Centre · NLDepartment of Health · TW

Funding

ZonMw 50-50405-98-133
6 · The paper itself

Abstract

backgroundFrom early 2009, the Dutch region of South Limburg experienced a massive outbreak of Q fever, overlapping with the influenza A(H1N1)pdm09 pandemic during the second half of the year and affecting approximately 2.9% of a 300,000 population. Acute Q fever shares clinical features with other respiratory conditions. Most symptomatic acute infections are characterized by mild symptoms, or an isolated febrile syndrome. Pneumonia was present in a majority of hospitalized patients during the Dutch 2007-2010 Q fever epidemic. Early empiric doxycycline, guided by signs and symptoms and patient history, should not be delayed awaiting laboratory confirmation, as it may shorten disease and prevent progression to focalized persistent Q fever. We assessed signs' and symptoms' association with acute Q fever to guide early empiric treatment in primary care patients.

methodsIn response to the outbreak, regional primary care physicians and hospital-based medical specialists tested a total of 1218 subjects for Q fever. Testing activity was bimodal, a first "wave" lasting from March to December 2009, followed by a second "wave" which lasted into 2010 and coincided with peak pandemic influenza activity. We approached all 253 notified acute Q fever cases and a random sample of 457 Q fever negative individuals for signs and symptoms of disease. Using data from 140/229(61.1%) Q fever positive and 194/391(49.6%) Q fever negative respondents from wave 1, we built symptom-based models predictive of Q-fever outcome, validated against subsets of data from wave 1 and wave 2.

resultsOur models had poor to moderate AUC scores (0.68 to 0.72%), with low positive (4.6-8.3%), but high negative predictive values (91.7-99.5%). Male sex, fever, and pneumonia were strong positive predictors, while cough was a strong negative predictor of acute Q fever in these models.

conclusionWhereas signs and symptoms of disease do not appear to predict acute Q fever, they may help rule it out in favour of other respiratory conditions, prompting a delayed or non-prescribing approach instead of early empiric doxycycline in primary care patients with non-severe presentations. Signs and symptoms thus may help reduce the overuse of antibiotics in primary care during and following outbreaks of Q fever.

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsCase-Control StudiesChildChild, PreschoolCoughDisease OutbreaksDoxycyclineFemaleFeverHumansInfantMaleAnti-Bacterial AgentsDoxycyclineAntibioticsCoxiella burnetiiPredictionPrimary careQ feverRespiratory tract infection

Identifiers

PMID32957938
PMCPMC7503428
OpenAlexW3087595668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.